[1]Mikosch P, Aistleitner A, Oehrlein M, et al. Hashimoto's thyroiditis and coexisting disorders in correlation with HLA status-an overview[J]. Wien Med Wochenschr, 2023, 173(1-2): 41-53. DOI: 10.1007/s10354-021-00879-x.
[2]房方,刘雅馨,冯文利,等.补充维生素D在桥本甲状腺炎动物模型中的作用及其机制研究[J].中华内分泌代谢杂志,2024,40(6):515-520. DOI:10.3760/cma.j.cn311282-20231026-00136.
[3]姚文杰,宋凯雨,姜冠桐,等.桥本甲状腺炎的研究进展[J].国际医药卫生导报, 2023, 29(6): 741-744. DOI:10.3760/cma.j.issn.1007-1245.2023.06.001.
[4]唐慧芸,刁洁华,方佳良,等.老年血脂异常患者亚临床性甲状腺功能减退症患病率和影响因素分析[J].老年医学与保健,2023,29(4):823-827. DOI:10.3969/j.issn.1008-8296. 2023.04.034.
[5]Capozzi A, Scambia G, Lello S. Subclinical hypothyroidism in women's health: from pre- to post-menopause[J]. Gynecol Endocrinol, 2022,38(5):357-367. DOI:10.1111/cts.12993.
[6]江帆,刘宁,翟鑫,等.亚临床甲状腺功能减退症患者TSH与肾上腺皮质功能的关系[J].中南医学科学杂志,2023,51(1):90-92. DOI:10.15972/j.cnki.43-1509/r.2023.01.023.
[7]Han E, Lee YH, Ahn SH, et al. Appendicular skeletal muscle mass to visceral fat area ratio predicts hepatic morbidities[J]. Gut Liver, 2024,18(3):509-519. DOI:10.5009/gnl230238.
[8]车炜琦,刘倩倩,傅松波,等.肥胖人群亚临床甲状腺功能减退症患病率及相关因素分析[J].兰州大学学报(医学版), 2024, 50(10): 28-35. DOI:10.13885/j.issn.1000- 2812.2024.10.004.
[9]Kumar Singh N, Suri A, Kumari M, et al. A study on serum homocysteine and oxidized LDL as markers of cardiovascular risk in patients with overt hypothyroidism[J]. Horm Mol Biol Clin Investig, 2022, 43(3): 329-335. DOI:10.1515/hmbci-2021-0029.
[10]中华医学会内分泌学分会«中国甲状腺疾病诊治指南»编写.中国甲状腺疾病诊治指南——甲状腺炎[J].中华内科杂志,2008,47(9):784-788. DOI: 10.3321/j.issn:0578-1426.2008.09.032.
[11]中华医学会内分泌学分会«中国甲状腺疾病诊治指南»编写组.甲状腺疾病诊治指南——甲状腺功能减退症[J].中华内科杂志,2007,46(11):967-971. DOI: 10.3760/j.issn:0578-1426.2007.11.032.
[12]杨雨菲,张庚良,何艳玲,等.温肾健脾疏肝膏方治疗桥本甲状腺炎合并甲减疗效及对Th1/Th2相关细胞因子的影响[J].现代中西医结合杂志,2023,32(10):1353-1358,1389. DOI: 10.3969/j.issn.1008-8849.2023.10.007.
[13]Huwiler VV, Maissen-Abgottspon S, Stanga Z, et al. Selenium supplementation in patients with Hashimoto thyroiditis: a systematic review and meta-analysis of randomized clinical trials[J]. Thyroid, 2024, 34(3): 295-313. DOI: 10.1089/thy.2023.0556.
[14]赵文娣,吴晨辰,薛丽,等. 2型糖尿病人群内脏脂肪面积与甲状腺激素的相关性分析[J].蚌埠医学院学报,2024,49(7):870-874. DOI:10.13898/j.cnki.issn.1000-2200. 2024.07.007.
[15]Jia X, Du L, Ma H, et al. Visceral and subcutaneous adipose tissue, which one induced thyroid dysfunction in patients with morbid obesity[J]. Surg Obes Relat Dis, 2021, 17(6):1175-1181. DOI:10.1016/j.soard.2021.02.012.
[16]Pan Q, Gao S, Gao X, et al. Relation of kidney function and homocysteine in patients with hypothyroidism[J]. Endocr Connect, 2021, 10(5): 502-510. DOI:10.1530/EC-21-0069.
[17]李凯,王亚雯,吕小羽,等.内脏脂肪面积与2型糖尿病患者亚临床性甲状腺功能减退症相关性的研究[J].中国医药导报,2024,21(6):82-85. DOI:10.20047/j.issn1673- 7210.2024.06.19.
[18]马望雯,赵燕萍,李文亚.亚临床甲状腺功能减退症患者血脂和Hcy水平及其与TSH的关系分析[J].河北医学,2024,30(7):1130-1134. DOI:10.3969/j.issn.1006-6233. 2024.07.013.
[19]周建平,费健,高平,等.亚硒酸钠对桥本甲状腺炎甲减患者血清TPO-Ab滴度及氧化应激水平的影响[J].标记免疫分析与临床,2022,29(1):32-35. DOI: 10.11748/bjmy.issn.1006-1703.2022.01.008.
[20]Wang L, Tang Y, Yuan Y, et al. Effects of thyroperoxidase antibody and thyroglobulin antibody on maternal and neonatal outcomes in pregnant women [J]. Horm Metab Res, 2022, 54(2): 76-83. DOI:10.1055/a-1731-7572.
[21]王明星,臧炫月.血清TSH及TPOAb、TgAb水平在桥本氏甲状腺炎中的表达及临床意义分析[J].中华内分泌外科杂志,2023,17(6):729-733. DOI: 10.3760/cma.j.cn.115807-20230328-00092.
[22]Ross DS. Treating hypothyroidism is not always easy: when to treat subclinical hypothyroidism, TSH goals in the elderly, and alternatives to levothyroxine monotherapy[J]. J Intern Med, 2022, 291(2): 128-140. DOI:10.1111/joim.13410.
[23]Urgatz B, Razvi S. Subclinical hypothyroidism, outcomes and management guidelines: a narrative review and update of recent literature[J]. Curr Med Res Opin, 2023, 39(3): 351-365. DOI: 10.1080/03007995.2023.2165811.
|